Hormone Therapy

Reported menopause symptoms and prescriptions for hormone therapy were less common among Black and Hispanic female veterans, highlighting disparities in the discussion, documentation and management of menopause, according to researchers.

In the past 20 years, researchers have refined knowledge on the benefits and risks of hormone therapy for symptoms associated with menopause.

During the past 2 decades, Endocrine Today has reported on the latest developments in hormone therapy for symptoms associated with menopause. For its 20th year, the publication is taking a look back.

The FDA has given final approval for an oral testosterone undecanoate therapy for men with a deficiency or absence of endogenous testosterone or hypogonadism, according to an industry press release.

Postmenopausal women taking hormone therapy have a duodenal microbiome similar to younger women and a lower abundance of taxaassociated with cardiovascular disease risk compared with those not taking HT, researchers reported.

The American Association of Clinical Endocrinology is opposing legislation to limit access to transgender care for adolescents and criminalize health care professionals providing transgender care for youths, according to a press release.

Histrelin implants are effective in sustaining pubertal suppression for more than 1 year in most transgender adolescents and children with central precocious puberty, according to study results published in Transgender Health.

The Endocrine Society condemned a new Texas directive that defines gender-affirming care in children, such as reassignment surgeries and hormone treatment, as “child abuse.” It was the top story in endocrinology last week.

The Endocrine Society is condemning a new directive issued by Texas Gov. Greg Abbott defining gender care for adolescents as “child abuse,” according to a press release from the organization.

Testosterone undecanoate injected at 8-week intervals for men with hypogonadism may reduce fluctuations and increase mean testosterone levels compared with a 10-week dose regimen, according to data from a modeling study.